Cameron Munter, Director of CareCloud, Inc. (NASDAQ:CCLD), recently sold 30,000 shares of the company's common stock. The transaction, which occurred on December 11, 2024, was completed at a price of $4.10 per share, for a total consideration of $122,999. The sale comes as CareCloud, which has a market cap of $55.7 million, has shown strong momentum with a 357% return over the past year, despite a recent 13% decline last week. Following this sale, Monter now directly owns 159,000 shares. The move comes amid ongoing developments at CareCloud, a company known for its pre-packaged software services. according to InvestingPro By analysis, the company maintains an “outstanding” financial health score, with analysts setting a high price target of $6.00. InvestingPro subscribers have access to 12 additional investment tips and comprehensive analysis of CCLD.
In other recent news, CareCloud, a healthcare technology company, has seen a series of important developments. Roth/MKM recently downgraded CareCloud stock from buy to neutral, setting a new price target of $3.50, citing weak 2025 growth outlook despite recent cost-cutting measures. This rating change comes on the heels of the company's third-quarter revenue report of $28.5 million, meeting analyst expectations, and an increase in adjusted EBITDA to $6.8 million.
On the financial front, CareCloud announced full repayment of its credit line and plans to resume dividend payments in March 2025. Despite the slight decline in revenue, the company's third-quarter earnings report showed a significant increase in free cash flow, reaching $10.3 million. An increase of 328% year-on-year.
In terms of strategic updates, CareCloud is focused on growth and operational efficiency with its CareCloud CirrusAI platform and in-house remote patient monitoring (RPM) solution. The company remains committed to its vision of transforming healthcare technology and delivering shareholder value. These are the latest developments in CareCloud's ongoing journey.
This article was created with the power of artificial intelligence and reviewed by an editor. For more information, see our terms and conditions.